Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Novo Nordisk

Novo Nordisk threatens to expand in US in row over EU rules

Novo Nordisk's CEO doesn't like proposed new EU rules that would cut the period for which drugmakers enjoy exclusivity for their products from 10 years to eight years.

Ozempic's rebranded weight-loss drug should be available next year

Ozempic's rebranded weight-loss drug should be available next year

'This is real and these medications are here to stay.'

Newcastle Herald

Novo Crushes Forecasts As Sales Of Weight-Loss Drug Rocket Eightfold

Novo Crushes Forecasts As Sales Of Weight-Loss Drug Rocket Eightfold

Novo Nordisk stock gapped up Thursday after reporting sweeping growth for weight-loss drug Wegovy, though Ozempic sales missed.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Novo Nordisk gives foodmakers $900 million reason to worry

Sales would have been higher if not for a shortfall following surging demand.

Sales soar at Danish firm behind weight-loss drug semaglutide

Novo Nordisk says it struggling to keep up with demand after becoming Europe’s most valuable company

The Guardian - UK

Dow Jones Futures Rise: Market Rally Gains Steam On Fed Chief Powell's 'Decay'; Palantir Jumps

Techs led futures higher, with Palantir and Roku among the big earnings winners. Fed chief Jerome Powell signaled no more rate hikes, fueling Wednesday's strong market rally.

Investors Business Daily

3 'Strong Buy' Dividend Stocks That Are Beating the Market

Here are three top-rated dividend stocks that have outperformed the S&P 500 in the past month, despite a tough environment for equities.

inkl

Read news from The Economist, FT, and more,
with one subscription

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?

The good times keep rolling for Novo Nordisk and its weight-loss drugs. But it's bad news for some medical device stocks.

Investors Business Daily

Warning as patients hospitalised after taking fake Ozempic weight-loss drug

Warning as patients hospitalised after taking fake Ozempic weight-loss drug

Hundreds of fake Ozempic jabs from the black market have been seied by the regulator

The Independent UK

3 Top-Rated Growth Stocks To Buy on Every Dip

3 Top-Rated Growth Stocks To Buy on Every Dip

Growth stocks are down, but don't count them out. Here are three top-rated names worth scooping up when the market pulls back.

Fears over black market weight loss drugs as people left seriously ill from counterfeit Ozempic

Fears over black market weight loss drugs as people left seriously ill from counterfeit Ozempic

Austria’s criminal investigation service warned on Monday that fake injection pens may still be in circulation

The Independent UK

Stock Market Rallies, Hits Resistance; Novo Nordisk, JPMorgan, Exxon In Focus: Weekly Review

Stock Market Rallies, Hits Resistance; Novo Nordisk, JPMorgan, Exxon In Focus: Weekly Review

The major indexes rallied for the week, but hit resistance at key levels amid weak stock market breadth. Novo Nordisk, JPMorgan, Exxon were in focus.

Investors Business Daily

Aust shares close a smidge higher to extend win streak

Aust shares close a smidge higher to extend win streak

The local share market has technically extended its winning streak to six days, with seven of the ASX's 11 sectors finishing in the green.

Stock Market Near The Day's Lows; AI-Focused Consulting Stock In Buy Zone

Stock Market Near The Day's Lows; AI-Focused Consulting Stock In Buy Zone

The stock market weakened in midday action as investors rethought higher-than-expected consumer price data, leaving major indexes mixed.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Why Novo's Good News For Ozempic Slammed Dialysis Stocks DaVita And Fresenius

Novo Nordisk stock popped Wednesday after the company hinted Ozempic showed early promise in kidney disease treatment.

Novo Nordisk, Eli Lilly leap as Ozempic shows promise in kidney patient treatment

Ozempic, the diabetes treatment often prescribed for weight loss, is also proving highly effective in treating patients with chronic kidney disease.

Investors Business Daily

Dow Jones Futures Rise After Market Rally Hits Resistance; Tesla, Nvidia Lead New Buys

The stock market rally continued to advance, but the Nasdaq hit key resistance. Tesla and Nvidia offered new entries.

Investors Business Daily

Weight-Loss Drugs Aren't To Blame For The Snack Pullback. Pepsi Offers This Reason.

Weight-loss drugs aren't the reason for suppressed shopping cart spending in a shaky economy, Pepsi executives say.

Get all your
news in one place.

100’s of premium titles.
One news app.

Wall Street is now betting against restaurant stocks because of Novo Nordisk’s Ozempic and high interest rates

Short positions on companies such as McDonald’s and Starbucks have increased in the last month, and weight loss drugs are part of the reason why.

Rare Ozempic side effects emerging

Though side effects from Ozempic are rare, as usage rises some side effects are becoming more apparent

The Independent UK

Warning over ‘severe’ weight-loss jab side effects

Semaglutide and liraglutide are sold under the brand names Wegovy, Ozempic, Rybelsus and Saxenda and are manufactured by Novo Nordisk

The Independent UK

Weight-loss jabs linked to ‘severe’ stomach problems – study

Researchers said instances were ‘rare’ but hundreds of thousands of people could still be affected due to the drugs’ popularity globally.

Weight loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says

The drugs, although not officially approved for use in weight loss, have been touted as a “miracle” treatments for obesity.

Weight-loss drugs like Ozempic have so much promise a major bank is telling investors to short junk food stocks

Barclays strategists expect "disruption into a number of industries," thanks to drugs like Novo Nordisk's Ozempic and Wegovy.

The Independent UK

Wegovy weight-loss jab 'significantly' improves blood sugar in diabetics

Hailed as potential ‘game changer’ in tackling obesity, Semaglutide can also help those with type 2 diabetes

1 … 10 11 12 13

People

Ihor Dusaniwsky

Fatima Cody Stanford

Lars Fruergaard Jørgensen

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

235,767 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play